<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>21924215</identifier>
<setSpec>1885-1398</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Arboleya, Luis</dc:author>
<dc:description xml:lang="en">Chronic renal failure (CRF) is frequent in patients with osteoporosis and the rheumatologist should be familiarized with basic diagnostic and treatment guidelines for bone mineral disease associated to this process. In patients with osteoporosis and stage I and II CRF, diagnosis and treatment does not vary from that in patients with normal RF. In stage III CRF, the focus will depend on the result of testing. In advanced stage CRF the approach should be coordinated with a nephrologist. In these cases it is possible to use antiresorptive agents although in well-selected and studied patients. The present review analyzes recent advances in this field with a focus on daily clinical practice.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>2011 Sep </dc:date>
<dc:title xml:lang="es">Trastorno mineral y óseo asociado a la enfermedad renal crónica.</dc:title>
<dc:title xml:lang="en">[Mineral and bone disorders associated with chronic kidney disease].</dc:title>
<dc:publisher>Reumatologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
